Pilot/Pivotal Study of DBS+Rehab After Stroke

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age21+
SponsorEnspire DBS Therapy, Inc.

About this trial

The RESTORE Stroke Study will evaluate the safety and effectiveness of DBS+Rehab for treating arm weakness and reduced function after a stroke.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ischemic stroke, with an initial incident occurring between 12 months to 6 years before implant, resulting in residual upper extremity hemiparesis.

Disqualifiers

Previous or subsequent cerebrovascular events resulting in residual upper extremity impairment

Brain lesions with significant involvement of the brainstem, cerebellum, or thalamus

Trial design

Design model

Parallel

Treatments tested in this trial

  • Deep Brain Stimulation

    Device

    Deep Brain Stimulation (DBS) of the dentate nucleus area of the cerebellum plus motor rehabilitation to improve upper-extremity function.

  • Rehabilitation

    Other intervention

    Motor rehabilitation to improve upper-extremity function.

Treatment groups

202 Participants
are divided into 2 treatment groups
Group A: DBS+RehabExperimental treatment 1 intervention
Group B: RehabActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Fugl-Meyer Assessment, Upper Extremity sub-scale (FMA-UE)

The change in FMA-UE is significantly greater for subjects who receive Test treatment (Tt) than Control treatment (Ct).

Time frame
Week-12 to Week-32

Secondary outcomes

1

Fugl-Meyer Assessment, Upper Extremity sub-scale (FMA-UE)

The change in FMA-UE for subjects who receive Test treatment (Tt) is significantly above a clinically important difference (CID)

Time frame
Week-12 to Week-32

Other outcomes

1

Fugl-Meyer Assessment, Upper Extremity sub-scale (FMA-UE)

Exploratory endpoints will be examined for the group originally assigned to Control treatment after crossover.

Time frame
Week-32, Week-40 and Week 52

Sponsors and contacts

Click on the lead sponsor to view all of their trials.